rs140083803

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005120.3(MED12):​c.6045-24C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,208,727 control chromosomes in the GnomAD database, including 97 homozygotes. There are 5,416 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 12 hom., 362 hem., cov: 22)
Exomes 𝑓: 0.015 ( 85 hom. 5054 hem. )

Consequence

MED12
NM_005120.3 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0420

Publications

1 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-71140611-C-T is Benign according to our data. Variant chrX-71140611-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 259640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0115 (1278/110715) while in subpopulation NFE AF = 0.017 (898/52897). AF 95% confidence interval is 0.0161. There are 12 homozygotes in GnomAd4. There are 362 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005120.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED12
NM_005120.3
MANE Select
c.6045-24C>T
intron
N/ANP_005111.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED12
ENST00000374080.8
TSL:1 MANE Select
c.6045-24C>T
intron
N/AENSP00000363193.3
MED12
ENST00000374102.6
TSL:1
c.6054-24C>T
intron
N/AENSP00000363215.2
MED12
ENST00000690523.1
n.2131C>T
non_coding_transcript_exon
Exon 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1278
AN:
110661
Hom.:
12
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00214
Gnomad AMI
AF:
0.141
Gnomad AMR
AF:
0.0129
Gnomad ASJ
AF:
0.000379
Gnomad EAS
AF:
0.000283
Gnomad SAS
AF:
0.000764
Gnomad FIN
AF:
0.0107
Gnomad MID
AF:
0.00840
Gnomad NFE
AF:
0.0170
Gnomad OTH
AF:
0.0128
GnomAD2 exomes
AF:
0.00987
AC:
1775
AN:
179847
AF XY:
0.00967
show subpopulations
Gnomad AFR exome
AF:
0.00121
Gnomad AMR exome
AF:
0.00603
Gnomad ASJ exome
AF:
0.000937
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0114
Gnomad NFE exome
AF:
0.0170
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.0146
AC:
16081
AN:
1098012
Hom.:
85
Cov.:
32
AF XY:
0.0139
AC XY:
5054
AN XY:
363384
show subpopulations
African (AFR)
AF:
0.00182
AC:
48
AN:
26399
American (AMR)
AF:
0.00682
AC:
240
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00119
AC:
23
AN:
19383
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30205
South Asian (SAS)
AF:
0.000296
AC:
16
AN:
54145
European-Finnish (FIN)
AF:
0.0118
AC:
479
AN:
40492
Middle Eastern (MID)
AF:
0.00387
AC:
16
AN:
4135
European-Non Finnish (NFE)
AF:
0.0175
AC:
14728
AN:
841962
Other (OTH)
AF:
0.0115
AC:
529
AN:
46087
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
632
1265
1897
2530
3162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1278
AN:
110715
Hom.:
12
Cov.:
22
AF XY:
0.0110
AC XY:
362
AN XY:
32931
show subpopulations
African (AFR)
AF:
0.00213
AC:
65
AN:
30447
American (AMR)
AF:
0.0128
AC:
132
AN:
10335
Ashkenazi Jewish (ASJ)
AF:
0.000379
AC:
1
AN:
2641
East Asian (EAS)
AF:
0.000284
AC:
1
AN:
3525
South Asian (SAS)
AF:
0.000767
AC:
2
AN:
2609
European-Finnish (FIN)
AF:
0.0107
AC:
63
AN:
5871
Middle Eastern (MID)
AF:
0.00922
AC:
2
AN:
217
European-Non Finnish (NFE)
AF:
0.0170
AC:
898
AN:
52897
Other (OTH)
AF:
0.0127
AC:
19
AN:
1501
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
47
95
142
190
237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
110
Bravo
AF:
0.0120

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
6.1
DANN
Benign
0.71
PhyloP100
-0.042
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140083803; hg19: chrX-70360461; API